SCHEMBL4052293

SCHEMBL4052293

CN(C)c1nc2sc(C(N)=O)c(N)c2c2c1CC(C)(C)C2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.53
MAPT P10636 5/20 0.53
HTT P42858 4/20 0.53
ATM Q13315 3/20 0.53
NPC1 O15118 1/20 0.53
CDK8 P49336 2/20 0.50
CDK19 Q9BWU1 2/20 0.50
EEF2K O00418 9/20 0.47
TDP1 Q9NUW8 2/20 0.47
HPGD P15428 3/20 0.46
ALDH1A1 P00352 5/20 0.46
GAA P10253 2/20 0.46
USP2 O75604 1/20 0.46
GLA P06280 1/20 0.46
HSD17B10 Q99714 1/20 0.46
RCE1 Q9Y256 1/20 0.46
LIMK1 P53667 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
IKBKB O14920 1/20 0.44
CHUK O15111 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4051773 0.91 EEF2K (0.54) KDM4EMAPTHTTATMNPC1
SCHEMBL4049074 0.89 CDK8 (0.50) KDM4EMAPTHTTATMNPC1
SCHEMBL5015905 0.85 KDM4E (0.64) KDM4EMAPTHTTATMNPC1
SCHEMBL4048241 0.83 HTT (0.47) KDM4EMAPTHTTATMNPC1
SCHEMBL4047809 0.81 EEF2K (0.52) KDM4EMAPTHTTATMNPC1
SCHEMBL4047574 0.80 EEF2K (0.55) KDM4EMAPTHTTATMNPC1
SCHEMBL4054324 0.80 KDM4E (0.69) KDM4EMAPTHTTATMNPC1
SCHEMBL4046258 0.77 MAPT (0.69) KDM4EMAPTHTTATMNPC1
SCHEMBL4049072 0.75 CDK8 (0.48) KDM4EMAPTHTTATMNPC1
SCHEMBL4051300 0.74 KDM4E (0.71) KDM4EMAPTHTTATMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1819710-B1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES ALMIRALL LAB (ES) 2009-03-11 EP disclosed
US-20090029955-A1 Pyridothienopyrimidine Derivatives ALMIRALL PRODESFARMA S.A. (ES) 2009-01-29 US disclosed
EP-1819710-A1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES Laboratorios Almirall, S.A. (ES) 2007-08-22 EP disclosed
WO-2006058724-A1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES LABORATORIOS ALMIRALL, S.A. (ES) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029955-A1 Pyridothienopyrimidine Derivatives PNPO, PDE4A, DPYD KDM4E 1600/4885MAPT 2618/4885HTT 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.